The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Targeting heat shock proteins in cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wu, L., Xu, J., Zhang, K. Z., Lin, Q., Huang, X. W., Wen, C., & Chen, Y. Z. (2008) · Leukemia · doi:10.1038/leu.2008.89 · Cited by 43
RetractedHSP90 and the chaperoning of cancer
Whitesell, L., & Lindquist, S. L. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1716 · Cited by 2,502
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
Kamal, A., Thao, L., Sensintaffar, J., Zhang, L., Boehm, M. F., Fritz, L. C., & Burrows, F. J. (2003) · Nature · doi:10.1038/nature01913 · Cited by 1,387
Stebbins, C. E., Russo, A. A., Schneider, C., Rosen, N., Hartl, F. U., & Pavletich, N. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80203-2 · Cited by 1,364
Pathways of chaperone-mediated protein folding in the cytosol
Young, J. C., Agashe, V. R., Siegers, K., & Hartl, F. U. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1492 · Cited by 1,105
Chalmin, F., Ladoire, S., Mignot, G., Vincent, J., Bruchard, M., Remy-Martin, J.-P., Boireau, W., Rouleau, A., Simon, B., Lanneau, D., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40483 · Cited by 998
Self-citationHsp27 negatively regulates cell death by interacting with cytochrome c
Bruey, J.-M., Ducasse, C., Bonniaud, P., Ravagnan, L., Susin, S. A., Diaz-Latoud, C., Gurbuxani, S., Arrigo, A.-P., Kroemer, G., Solary, E., et al. (2000) · Nature Cell Biology · doi:10.1038/35023595 · Cited by 985
Self-citationHeat shock proteins in cancer: chaperones of tumorigenesis
Calderwood, S. K., Khaleque, M. A., Sawyer, D. B., & Ciocca, D. R. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.01.006 · Cited by 957
Heat-shock protein 70 antagonizes apoptosis-inducing factor
Ravagnan, L., Gurbuxani, S., Susin, S. A., Maisse, C., Daugas, E., Zamzami, N., Mak, T., Jäättelä, M., Penninger, J. M., Garrido, C., et al. (2001) · Nature Cell Biology · doi:10.1038/ncb0901-839 · Cited by 858
Self-citationHeat Shock Proteins 27 and 70: Anti-Apoptotic Proteins with Tumorigenic Properties
Garrido, C., Brunet, M., Didelot, C., Zermati, Y., Schmitt, E., & Kroemer, G. (2006) · Cell Cycle · doi:10.4161/cc.5.22.3448 · Cited by 676
Self-citationSmall Stress Proteins as Novel Regulators of Apoptosis
Mehlen, P., Schulze-Osthoff, K., & Arrigo, A.-P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.28.16510 · Cited by 607
Eustace, B. K., Sakurai, T., Stewart, J. K., Yimlamai, D., Unger, C., Zehetmeier, C., Lain, B., Torella, C., Henning, S. W., Beste, G., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1131 · Cited by 590
Mice Lacking Histone Deacetylase 6 Have Hyperacetylated Tubulin but Are Viable and Develop Normally
Zhang, Y., Kwon, S., Yamaguchi, T., Cubizolles, F., Rousseaux, S., Kneissel, M., Cao, C., Li, N., Cheng, H.-L., Chua, K., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01154-06 · Cited by 559
Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent
Supko, J. G., Hickman, R. L., Grever, M. R., & Malspeis, L. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00689048 · Cited by 510
Heat shock proteins: essential proteins for apoptosis regulation
Lanneau, D., Brunet, M., Frisan, E., Solary, E., Fontenay, M., & Garrido, C. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00273.x · Cited by 501
Self-citationHeat shock proteins as cellular lifeguards
Jäättelä, M. (1999) · Annals of Medicine · doi:10.3109/07853899908995889 · Cited by 486
Diverse Cellular Functions of the Hsp90 Molecular Chaperone Uncovered Using Systems Approaches
McClellan, A. J., Xia, Y., Deutschbauer, A. M., Davis, R. W., Gerstein, M., & Frydman, J. (2007) · Cell · doi:10.1016/j.cell.2007.07.036 · Cited by 474
A Small Molecule Inhibitor of Inducible Heat Shock Protein 70
Leu, J. I.-J., Pimkina, J., Frank, A., Murphy, M. E., & George, D. L. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.023 · Cited by 441
New approaches to molecular cancer therapeutics
Collins, I., & Workman, P. (2006) · Nature Chemical Biology · doi:10.1038/nchembio840 · Cited by 391
Heat Shock Proteins 70 and 90 Inhibit Early Stages of Amyloid β-(1–42) Aggregation in Vitro
Evans, C. G., Wisén, S., & Gestwicki, J. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606192200 · Cited by 382
Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology
Kostenko, S., & Moens, U. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0086-3 · Cited by 360
High HSP90 Expression Is Associated with Decreased Survival in Breast Cancer
Pick, E., Kluger, Y., Giltnane, J. M., Moeder, C., Camp, R. L., Rimm, D. L., & Kluger, H. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4511 · Cited by 356
Bedi, A., Barber, J., Bedi, G., el-Deiry, W., Sidransky, D., Vala, M., Akhtar, A., Hilton, J., & Jones, R. (1995) · Blood · doi:10.1182/blood.v86.3.1148.1148 · Cited by 349
Shi, Y., & Thomas, J. O. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.5.2186 · Cited by 343
Rational design of shepherdin, a novel anticancer agent
Plescia, J., Salz, W., Xia, F., Pennati, M., Zaffaroni, N., Daidone, M. G., Meli, M., Dohi, T., Fortugno, P., Nefedova, Y., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.035 · Cited by 341
Modi, S., Stopeck, A. T., Gordon, M. S., Mendelson, D., Solit, D. B., Bagatell, R., Ma, W., Wheler, J., Rosen, N., Norton, L., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.7960 · Cited by 335
Rocchi, P., So, A., Kojima, S., Signaevsky, M., Beraldi, E., Fazli, L., Hurtado-coll, A., Yamanaka, K., & Gleave, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3998 · Cited by 316
Caldas-Lopes, E., Cerchietti, L., Ahn, J. H., Clement, C. C., Robles, A. I., Rodina, A., Moulick, K., Taldone, T., Gozman, A., Guo, Y., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903392106 · Cited by 315
Massey, A. J., Williamson, D. S., Browne, H., Murray, J. B., Dokurno, P., Shaw, T., Macias, A. T., Daniels, Z., Geoffroy, S., Dopson, M., et al. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1194-3 · Cited by 313
Dual Targeting of HSC70 and HSP72 Inhibits HSP90 Function and Induces Tumor-Specific Apoptosis
Powers, M. V., Clarke, P. A., & Workman, P. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.08.002 · Cited by 307
Chiosis, G., Timaul, M. N., Lucas, B., Munster, P. N., Zheng, F. F., Sepp-Lorenzino, L., & Rosen, N. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00015-1 · Cited by 288
A New Antifungal Substance of Fungal Origin
DELMOTTE, P., & DELMOTTE-PLAQUEE, J. (1953) · Nature · doi:10.1038/171344a0 · Cited by 271
Heat shock protein 70 binding inhibits the nuclear import of apoptosis-inducing factor
Gurbuxani, S., Schmitt, E., Cande, C., Parcellier, A., Hammann, A., Daugas, E., Kouranti, I., Spahr, C., Pance, A., Kroemer, G., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206794 · Cited by 266
Self-citationThe regulatory mechanism of Hsp90α secretion and its function in tumor malignancy
Wang, X., Song, X., Zhuo, W., Fu, Y., Shi, H., Liang, Y., Tong, M., Chang, G., & Luo, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908151106 · Cited by 259
Blockade of Hsp27 overcomes Bortezomib/proteasome inhibitor PS-341 resistance in lymphoma cells.
Chauhan, D., Li, G., Shringarpure, R., Podar, K., Ohtake, Y., Hideshima, T., & Anderson, K. C. (2003) · PubMed · Cited by 252
Apoptosis Versus Cell Differentiation: Role of Heat Shock Proteins HSP90, HSP70 and HSP27
Lanneau, D., de Thonel, A., Maurel, S., Didelot, C., & Garrido, C. (2007) · Prion · doi:10.4161/pri.1.1.4059 · Cited by 235
Self-citationChemical Manipulation of Hsp70 ATPase Activity Regulates Tau Stability
Jinwal, U. K., Miyata, Y., Koren, J., Jones, J. R., Trotter, J. H., Chang, L., O'Leary, J., Morgan, D., Lee, D. C., Shults, C. L., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3345-09.2009 · Cited by 228
Williamson, D. S., Borgognoni, J., Clay, A., Daniels, Z., Dokurno, P., Drysdale, M. J., Foloppe, N., Francis, G. L., Graham, C. J., Howes, R., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801627a · Cited by 227
Cheung, K.-M. J., Matthews, T. P., James, K., Rowlands, M. G., Boxall, K. J., Sharp, S. Y., Maloney, A., Roe, S. M., Prodromou, C., Pearl, L. H., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.05.046 · Cited by 219
Guo, F., Rocha, K., Bali, P., Pranpat, M., Fiskus, W., Boyapalle, S., Kumaraswamy, S., Balasis, M., Greedy, B., Armitage, E. S. M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1799 · Cited by 212
Heat Shock Protein 70 Is Required for the Survival of Cancer Cells
NYLANDSTED, J., BRAND, K., & JÄÄTTELÄ, M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05605.x · Cited by 200
High-throughput screening assay for inhibitors of heat-shock protein 90 ATPase activity
Rowlands, M. G., Newbatt, Y. M., Prodromou, C., Pearl, L. H., Workman, P., & Aherne, W. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2003.10.038 · Cited by 199
The Mechanisms of hsp27 Antibody-Mediated Apoptosis in Retinal Neuronal Cells
Tezel, G., & Wax, M. B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-10-03552.2000 · Cited by 197
Altered states: selectively drugging the Hsp90 cancer chaperone
Workman, P. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.12.005 · Cited by 195
Rao, R., Fiskus, W., Yang, Y., Lee, P., Joshi, R., Fernandez, P., Mandawat, A., Atadja, P., Bradner, J. E., & Bhalla, K. (2008) · Blood · doi:10.1182/blood-2008-03-143644 · Cited by 188
Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones.
Garrido, C., Fromentin, A., Bonnotte, B., Favre, N., Moutet, M., Arrigo, A., Mehlen, P., & Solary, É. (1998) · PubMed · Cited by 179
Self-citationInduction of Hsp90 protein expression in malignant melanomas and melanoma metastases
Becker, B., Multhoff, G., Farkas, B., Wild, P. ‐., Landthaler, M., Stolz, W., & Vogt, T. (2004) · Experimental Dermatology · doi:10.1111/j.0906-6705.2004.00114.x · Cited by 167
Cerchietti, L. C., Lopes, E. C., Yang, S. N., Hatzi, K., Bunting, K. L., Tsikitas, L. A., Mallik, A., Robles, A. I., Walling, J., Varticovski, L., et al. (2009) · Nature Medicine · doi:10.1038/nm.2059 · Cited by 161
Allan, R. K., Mok, D., Ward, B. K., & Ratajczak, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512406200 · Cited by 159
Lancet, J. E., Gojo, I., Burton, M., Quinn, M. F., Tighe, S., Kersey, K., Zhong, Z., Albitar, M. X., Bhalla, K. N., Hannah, A. L., et al. (2010) · Leukemia · doi:10.1038/leu.2009.292 · Cited by 156
Schmitt, E., Maingret, L., Puig, P., Rérole, A.-L., Ghiringhelli, F., Hammann, A., Solary, É., Kroemer, G., & Garrido, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3778 · Cited by 153
Self-citationEiseman, J. L., Lan, J. Q., Lagattuta, T. F., Hamburger, D. R., Joseph, E., Covey, J. M., & Egorin, M. J. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0865-3 · Cited by 152
Peng, C., Brain, J. M., Hu, Y., Goodrich, A., Kong, L., Grayzel, D., Pak, R. H., Read, M. A., & Li, S. (2007) · Blood · doi:10.1182/blood-2006-10-054098 · Cited by 150
Sharp, S. Y., Prodromou, C., Boxall, K. J., Powers, M. V., Holmes, J. L., Box, G., Matthews, T. P., Cheung, K.-M. J., Kalusa, A., James, K. E., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0149 · Cited by 145
Development of Radicicol Analogues
Soga, S., Shiotsu, Y., Akinaga, S., & Sharma, S. V. (2003) · Current Cancer Drug Targets · doi:10.2174/1568009033481859 · Cited by 143
Andrieu, C., Taïeb, D., Baylot, V., Ettinger, S., Soubeyran, P., de Thonel, A., Nelson, C. C., Garrido, C., So, A., Fazli, L., et al. (2010) · Oncogene · doi:10.1038/onc.2009.479 · Cited by 135
Self-citationChaperone proteostasis in Parkinson's disease: stabilization of the Hsp70/α‐synuclein complex by Hip
Roodveldt, C., Bertoncini, C. W., Andersson, A., van der Goot, A. T., Hsu, S. D., Fernández-Montesinos, R., de Jong, J., van Ham, T. J., Nollen, E. A. A., Pozo, D., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.298 · Cited by 130
Structural Studies on the Co-chaperone Hop and Its Complexes with Hsp90
Onuoha, S. C., Coulstock, E. T., Grossmann, J. G., & Jackson, S. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.02.013 · Cited by 127
Chandarlapaty, S., Scaltriti, M., Angelini, P. D., Ye, Q., Guzmán, M., Hudis, C. A., Norton, L., Solit, D. B., Arribas, J., Baselga, J. M., et al. (2009) · Oncogene · doi:10.1038/onc.2009.337 · Cited by 126
Kummar, S., Gutierrez, M. E., Gardner, E. R., Chen, X., Figg, W. D., Zajac‐Kaye, M., Chen, M., Steinberg, S. M., Muir, C. A., Yancey, M. A., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.10.026 · Cited by 122
A Novel Class of Small Molecule Inhibitors of Hsp90
Yi, F., & Regan, L. (2008) · ACS Chemical Biology · doi:10.1021/cb800162x · Cited by 116
Parcellier, A., Brunet, M., Schmitt, E., Col, E., Mirjolet, C., Hammann, A., Nakayama, K., Nakayama, K., Khochbin, S., Solary, É., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-4184fje · Cited by 110
Self-citationHsp90 Inhibitors in the Clinic
Pacey, S., Banerj, U., Judson, I. R., & Workman, P. (2005) · Springer eBooks · doi:10.1007/3-540-29717-0_14 · Cited by 109
Xia, Y., Liu, Y., Wan, J., Wang, M., Rocchi, P., Qu, F., Iovanna, J., & Peng, L. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900960v · Cited by 108
A phase I and pharmacokinetic study of the mitochondrial-specific rhodacyanine dye analog MKT 077.
Britten, C. D., Rowinsky, E. K., Baker, S. D., Weiss, G. R., Smith, L., Stephenson, J., Rothenberg, M. L., Smetzer, L., Cramer, J. A., Collins, W., et al. (2000) · PubMed · Cited by 103
Shiotsu, Y., Neckers, L. Μ., Wortman, I. A., An, W. G., Schulte, T. W., Soga, S., Murakata, C., Tamaoki, T., & Akinaga, S. (2000) · Blood · doi:10.1182/blood.v96.6.2284 · Cited by 102
Zoubeidi, A., Zardan, A., Wiedmann, R. M., Locke, J. A., Beraldi, E., Fazli, L., & Gleave, M. E. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3252 · Cited by 99
Shelton, S. N., Shawgo, M. E., Matthews, S. B., Lu, Y., Donnelly, A. C., Szabla, K., Tanol, M., Vielhauer, G. A., Rajewski, R. A., Matts, R. L., et al. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.058545 · Cited by 99
Chen, L., Meng, S., Wang, H., Bali, P., Bai, W., Li, B., Atadja, P. W., Bhalla, K. N., & Wu, J. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0287 · Cited by 99
Heat Shock Protein 90 Inhibition in Lung Cancer
Shimamura, T., & Shapiro, G. I. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318174ea3a · Cited by 88
Lin, T., Fenger, J. M., Murahari, S., Bear, M. D., Kulp, S. K., Wang, D.-S., Chen, C., Kisseberth, W. C., & London, C. A. (2010) · Blood · doi:10.1182/blood-2009-07-231985 · Cited by 85
The Interaction of Drugs with DNA Gyrase: A Model for the Molecular Basis of Quinolone Action
Heddle, J. G., Barnard, F. M., Wentzell, L. M., & Maxwell, A. (2000) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770008033048 · Cited by 83
Mortalin sensitizes human cancer cells to MKT-077-induced senescence
Deocaris, C. C., Widodo, N., Shrestha, B. G., Kaur, K., Ohtaka, M., Yamasaki, K., Kaul, S. C., & Wadhwa, R. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.038 · Cited by 80
Song, D., Chaerkady, R., Tan, A. C., García-García, E., Nalli, A., Suárez‐Gauthier, A., López‐Ríos, F., Zhang, X. F., Solomon, A., Tong, J. K., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0508 · Cited by 80
Tanespimycin: the opportunities and challenges of targeting heat shock protein 90
Erlichman, C. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902953699 · Cited by 79
Schmitt, E., Parcellier, A., Gurbuxani, S. K., Candé, C., Hammann, A., Morales, M. C., Hunt, C. R., Dix, D. J., Kroemer, R. T., Giordanetto, F., et al. (2003) · PubMed · Cited by 69
Self-citationExpression of heat shock protein 27 in human renal cell carcinoma
Sarto, C., Valsecchi, C., Magni, F., et al. (2004) · PROTEOMICS · doi:10.1002/pmic.200300797 · Cited by 68
Mirjolet, C., Lanneau, D., Brunet, M., Bouchot, A., Cartier, J., Jacquel, A., Ducoroy, P., Cathelin, S., Décologne, N., Chiosis, G., et al. (2008) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402320 · Cited by 66
Self-citationGenomic Mechanisms of p210BCR-ABL Signaling
Ray, S., Lu, Y. C., Kaufmann, S. H., Gustafson, W. C., Karp, J. E., Boldogh, I. R., Fields, A. P., & Brasier, A. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401851200 · Cited by 63
Böll, B., Eltaib, F. I., Reiners, K. S., von Tresckow, B., Tawadros, S., Simhadri, V. R., Burrows, F. J., Lundgren, K., Hansen, H. P., Engert, A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0213 · Cited by 62
Retaspimycin hydrochloride (IPI-504): a novel heat shock protein inhibitor as an anticancer agent
Hanson, B., & Vesole, D. H. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903158934 · Cited by 56
Garcia, M. C., Ray, D. M., Lackford, B. L., Rubino, M., Olden, K., & Roberts, J. D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.020271 · Cited by 54
A comparison of Hsp90α and Hsp90β interactions with cochaperones and substrates
Taherian, A., Krone, P. H., & Ovsenek, N. (2008) · Biochemistry and Cell Biology · doi:10.1139/o07-154 · Cited by 52
Hadaschik, B. A., Jackson, J. K., Fazli, L., Zoubeidi, A., Burt, H. M., Gleave, M. E., & So, A. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07669.x · Cited by 50
Steele, A. J., Prentice, A. G., Hoffbrand, A. V., Yogashangary, B. C., Hart, S., Lowdell, M. W., Samuel, E. R., North, J. M., Nacheva, E. P., Chanalaris, A., et al. (2009) · Blood · doi:10.1182/blood-2008-11-190587 · Cited by 50
Mirjolet, C., Lanneau, D., Brunet, M., Bouchot, A., Cartier, J., Jacquel, A., Ducoroy, P., Cathelin, S., Décologne, N., Chiosis, G., et al. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.5 · Cited by 49
Self-citationMatthews, S. B., Vielhauer, G. A., Manthe, C. A., et al. (2009) · The Prostate · doi:10.1002/pros.21035 · Cited by 47
Morrow, P. K. H., Zambrana, F. R., & Esteva, F. J. (2009) · Breast Cancer Research · doi:10.1186/bcr2324 · Cited by 46
GCUNC45 Is the First Hsp90 Co-chaperone to Show α/β Isoform Specificity
Chadli, A., Felts, S. J., & Toft, D. O. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800017200 · Cited by 44
Wright, C. M., Seguin, S. P., Fewell, S. W., Zhang, H., Ishwad, C., Vats, A. N., Lingwood, C. A., Wipf, P., Fanning, E., Pipas, J. M., et al. (2009) · Virus Research · doi:10.1016/j.virusres.2008.12.018 · Cited by 44
Geldanamycin inhibits TGF-β signaling through induction of Hsp70
Yun, C.-H., Yoon, S.-Y., Nguyen, T. T., Cho, H.-Y., Kim, T. H., Kim, S.-T., Kim, B.-C., Hong, Y., Kim, S., & Lee, H.-J. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.12.003 · Cited by 41
Song, T., Zhang, Z., Liu, L., Yang, T., Jiang, J., & Pl, L. (2009) · Journal of International Medical Research · doi:10.1177/147323000903700512 · Cited by 41
Robles, A. I., Wright, M. H., Gandhi, B., Feis, S. S., Hanigan, C. L., Wiestner, A. U., & Varticovski, L. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1178 · Cited by 39
Chang, Y., Lee, L.-C., Sun, F., Chao, C., Fu, H., & Lai, Y. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20623 · Cited by 38
Heat Shock Protein 90 Inhibitors: New Mode of Therapy to Overcome Endocrine Resistance
Wong, C., & Chen, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1259 · Cited by 35
Ayrault, O., Godeny, M. D., Dillon, C. P., Zindy, F., Fitzgerald, P., Roussel, M. F., & Beere, H. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902880106 · Cited by 33
Oba, M., Yano, S., Shuto, T., Suico, M., Eguma, A., & Kai, H. (1992) · International Journal of Oncology · doi:10.3892/ijo_32_6_1317 · Cited by 33
Palacios, C., López-Pérez, A. I., & López‐Rivas, A. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.06.012 · Cited by 19
Cited by
Induced protein degradation: an emerging drug discovery paradigm
Lai, A. C., & Crews, C. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.211 · Cited by 1,486
Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach
Chatterjee, S., & Burns, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091978 · Cited by 501
Programmed cell death in aging
Tower, J. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.04.002 · Cited by 426
Targeted Protein Degradation: from Chemical Biology to Drug Discovery
Cromm, P. M., & Crews, C. M. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.05.024 · Cited by 412
Precise nanomedicine for intelligent therapy of cancer
Chen, H., Gu, Z., An, H., Chen, C., Chen, J., Cui, R., Chen, S., Chen, W., Chen, X., Chen, X., et al. (2018) · Science China Chemistry · doi:10.1007/s11426-018-9397-5 · Cited by 409
Metadata
- Authors
- Jego, G., Hazoumé, A., Seigneuric, R., & Garrido, C.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 332
- Issue
- 2
- Pages
- 275-285
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W1998074678
- Cited by
- 452
- References
- 98
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.